Ribociclib

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Ribociclib and local guidelines before prescribing.

CDK4/6 inhibitor

Mechanism

CDK4/6 inhibitor.

Uses

HR-positive HER2-negative breast cancer.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Neutropenia, QT prolongation, hepatotoxicity, nausea.

Interactions

QT-prolonging drugs; CYP3A4 interactions.

Contraindications and cautions

QT prolongation

Monitoring

FBC, ECG, LFT

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Reduce dose in severe hepatic impairment

Overdose and reversal

Supportive

Special advice

ECG at baseline, day 14 and cycle 2.

More from the textbook: uses, cautions and other points
Where it is discussed in the book